Skip to main content
. 2017 Oct 24;8(58):98812–98822. doi: 10.18632/oncotarget.22003

Figure 2. The diagnostic powers of the e antigen positive liver fibrosis (EPLF) score, FiB-4, and APRI for predicting liver fibrosis in training set.

Figure 2

(A) ROC plot for EPLF score, Fib-4, and APRI in differentiating significant fibrosis(METAVIR≥F2) from mild fibrosis(MATAIRE F0-F1) in the training set. EPLF score had an AUROC of 0.84, as comparing, FIB-4 and APRI had an AUROC of 0.74 and 0.66 respectively. (B) ROC plot for EPLF score, Fib-4, and APRI in differentiating advanced fibrosis(METARIR≥F3) from mild to moderate fibrosis(METAVIR F0-F2) in the training set. EPLF score had an AUROC of 0.90, as comparing, FIB-4 and APRI had an AUROC of 0.78 and 0.67 respectively. (C) ROC plot for EPLF score, Fib-4, and APRI in diagnosis of cirrhosis(METAVIR, F4) in the training set. EPLF score had an AUROC of 0.87, as comparing, FIB-4 and APRI had an AUROC of 0.75 and 0.63 respectively.